Stocksigma LogoStocksigma Logo

Molbio Diagnostics Q1 FY27 Results: Strong Turnaround Driven by Truenat Kit Volumes

Molbio Diagnostics reported Q1 FY27 total income of ₹411.48 Cr, up sharply from ₹100.47 Cr in Q1 FY26, boosted by Truenat test kit volumes reaching 6.24 Mn

Molbio Diagnostics Q1 FY27 Results: Strong Turnaround Driven by Truenat Kit Volumes

Molbio Diagnostics Ltd · Press Release · 07 Sept 2026, 3:22 pm

Molbio Diagnostics Q1 FY27 Results: Strong Turnaround Driven by Truenat Kit Volumes Molbio Diagnostics reported Q1 FY27 total income of ₹411.48 Cr, up sharply from ₹100.47 Cr in Q1 FY26, boosted by Truenat test kit volumes reaching 6.24 Mn units and ~₹57 Cr in deferred Q4 FY26 export orders. The company turned profitable YoY, posting an EBITDA of ₹103.68 Cr (25.20% margin) versus a ₹14.50 Cr loss, and PAT of ₹52.74 Cr (12.82% margin) versus a ₹23.94 Cr loss. Following its 17th Aug'26 listing, IPO proceeds are funding automation and a Bengaluru R&D facility.

Original exchange filing (PDF)

More announcements from Molbio Diagnostics Ltd

All Molbio Diagnostics Ltd announcements